CARDIAC ASSIST DEVICES MARKET SIZE TO REACH USD 2.4 BILLION BY 2025, GROWING AT A CAGR OF 9% DURING THE FORECAST PERIOD

Cardiac Assist Devices Market Size, Share, & Trends Analysis Report by Application (Bridge To Transplant, Destination Therapy, and Others), Products (Intra-Aortic Balloon Pump, Ventricular Assist Devices, and Total Artificial Heart), End-Users (Hospitals and Special Cardiac Centers), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Global Analysis Report, Global Outlook, Market Trends, Competitive Landscape, Share, Growth Potential & Forecast, 2020-2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

245 Pages

icon-table

35 Tables

icon-chart

103 Charts

icon-region

5 Regions

icon-country

17 Countries

icon-company

14 Companies

icon-market

4 Market Segment

CARDIAC ASSIST DEVICES MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 2.4 BILLION (2025)
CAGR 9% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments Application (Bridge To Transplant, Destination Therapy, and Others), Products (Intra-Aortic Balloon Pump, Ventricular Assist Devices, and Total Artificial Heart), End-Users (Hospitals and Special Cardiac Centers)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, Germany, France, UK, Spain, Italy, Japan, China, Australia, South Korea, India, Brazil, Mexico, Argentina, Turkey, and Saudi Arabia

INDUSTRY INSIGHTS

The cardiac assist devices market size to reach USD 2.4 billion by 2025, growing at a CAGR of 9% during the forecast period. The global market is expected to grow at a significant pace during the forecast period due to growing technological advancements, new product approvals, increasing elderly population, and improvements in reimbursement policies for heart failure.

The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage. For instance, Abbott received the USFDA approval for its HeartMate 3 LVAD, which can be used for long-term circulatory support and as destination therapy in patients who are not eligible for heart transplantations.

The cardiac assist devices have evolved into an appropriate treatment option for patients with advanced heart failure. With growing technological advancements, cardiac assist devices have become popular across the globe, especially in developed countries such as the US, Germany, France, Spain, Japan, the UK, and Australia.

SNIPPETS

  • In the US, over 8 million people are expected to experience heart-related disorders by 2030, which is likely to boost the demand for cardiac assist devices.
  • The growth of the geriatric population in France, which is expected to reach 30% by 2050 from 25% in 2030, is likely to contribute to market growth.
  • In Spain, the high penetration of advanced cardiac assist devices is likely to influence the market positively.
  • In 2019, the ventricular assist devices market segment accounted for an 88% share of the global cardiac assist devices market share.

CARDIAC ASSIST DEVICES MARKET SEGMENTATION

This research report includes detailed segmentation by

  • Application
  • Products
  • End-users
  • Geography

INSIGHTS BY APPLICATION 

The cardiac assist devices market is segmented into the bridge to transplantation (BTT), destination therapy (DT), and other applications. BTT accounted for a 53% share in the global cardiac assist devices market. The bridge to candidacy (BTC) segment is expected to grow steadily due to advances in technology. The destination therapy (DT) segment is expected to grow at the fastest CAGR of 12% on account of the shortage of heart donors, increasing prevalence of end-stage heart failures, and the availability of effective therapies to treat heart failures. The demand for DT is likely to increase as it supports long-term cardiac function in end-stage heart failure patients, who are ineligible for heart transplantation.

INSIGHTS BY PRODUCTS 

The VADs product segment is growing at a significant rate and is likely to grow at a similar pace during the forecast period. The market is expected to reach USD 2.2 billion in 2025, growing at a CAGR of 10% during the forecast period. The LVADs market segment accounted for 82% of the global cardiac assist devices market. The usage of LVAD, like a heart pump, has significantly improved the survival rate of patients who are waiting for heart transplantation. LVADs are also evolving rapidly as its accessibility is increasing across the globe among the developed and few developing countries than transplantation.

Intra-aortic balloon pumps (IABP) are considered to be the first line of treatment, especially in low and middle-income countries, and help treat the patient at critical stages. The segment is expected to grow due to several surgeons recommending IABP for treating advanced heart failures.

INSIGHTS BY END-USERS 

The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings. Patients prefer undergoing advanced heart failure treatment in hospitals due to their convenient locations and ease of accessibility. Moreover, the aging population and shortage of heart donors are other major factors likely to drive the segment growth.

Specialty cardiac centers (SSCs) are solely dedicated to treating patients suffering from several cardiovascular diseases. The segment is expected to grow at the fastest CAGR due to the availability of sophisticated infrastructure related to the diagnosis and high-quality treatment of CVDs in standalone cardiology centers. This segment is likely to grow at a faster rate and increase its market share to 42% by 2025.

INSIGHTS BY GEOGRAPHY

The North American market heart transplant market is the major revenue-contributor and is expected to grow at the fastest CAGR of 11% due to favorable patient demographics, availability of skilled surgeons, and favorable reimbursement coverage. The increasing prevalence of obesity and diabetes, coupled with the aging population, has increased heart failures, which are expected to bolster the market.

Europe is the second-largest cardiac assist devices market and accounted for a share of 22% of the global market. In Europe, the market is likely to grow because of the increasing geriatric population with heart diseases and high awareness of the advantages of cardiac assist devices. Further, increased government investments for such devices are likely to boost industry growth. Germany, the UK, and France are the key countries in the region as they invest the highest in R&D activities than other European countries.

The APAC market is expected to grow at a moderate rate due to the increased healthcare expenditure, coupled with a high prevalence of CVDs. The market is likely to reach $246 million in 2025, growing at a CAGR of 6% during the forecast period. Japan, China, Australia, South Korea, and India are the major revenue contributors to the cardiac assist devices market in the APAC region.

INSIGHTS BY VENDORS

The global cardiac assist device market is highly consolidated with major players accounting for a significant share of the industry. Abbott, Medtronic, SynCardia, Getinge, and Abiomed are identified as the leading vendors in the market. However, there are considerable growth opportunities for new entrants. Several investigational and small med-tech companies are expected to offer innovative products and technologies. The leading players are focusing on implementing several strategies such as product launches and approvals, acquisitions, and an increase in R&D investment to enhance their market share. Leading players are likely to dominate the industry on account of their strong presence and surgeons’ endorsement for their products due to the availability of abundant clinical data and efficacy.

The cardiac assist devices market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Application

  • Bridge to Transplant
  • Destination Therapy
  • Others

By Product

  • Ventricular Assist Devices (VADs)
    • Left Ventricular Assist Devices (LVADs)
    • Other VADs
  • Intra-aortic Balloon Pump (IABP)
  • Total Artificial Heart (TAH)

By End-user  

  • Hospitals
  • Special Cardiac Centers

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia

Frequently Asked Questions

What is the cardiac assist devices market size and growth forecast?

The cardiac assist devices market size to reach revenues of USD 2.4 billion, growing at a CAGR of over 9% during 2019-2025.

What are the factors impacting the growth of the cardiac assist devices market?

The cardiac assist devices market is expected to observe significant growth on account of the growing incidence of congestive heart failures worldwide, especially in the geriatric population.

Who are the key players in the cardiac assist devices market

The leading players in the cardiac assist devices market include Abbott and Medtronic.

Which segment is fueling the cardiac assist devices market growth?

The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings.

What are the recent technological advancements in cardiac assist devices?

The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage.

Download Free Sample

The cardiac assist devices market is expected to grow at a CAGR of over 9% during the period 2019–2025.

 The following factors are likely to contribute to the growth of the cardiac assist devices market during the forecast period:

  • Growing Global Incidence of Heart Failure
  • Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation
  • Increasing demand for Shared Care Centers & their Importance Post-LVAD Implantation
  • Technological Advancements
  • New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices

 Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the cardiac assist devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • Abbott
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Medtronic

 Other Vendors

  • Abiomed
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Berlin Heart
  • Getinge
  • SynCardia
  • Teleflex
  • ZEON MEDICAL
  • Tokai Medical Products
  • SENKO MEDICAL INSTRUMENT
  • Insightra Medical
  • ReliantHeart
  • PulseCath
  • Jarvik Heart

Market Segmentation by Application  

  • Bridge to Transplant
  • Destination Therapy
  • Others

Market Segmentation by Product  

  • Intra-aortic Balloon Pump (IABP)
  • Ventricular Assist Devices (VADs)
    • Left Ventricular Assist Devices (LVADs)
    • Other VADs
  • Total Artificial Heart (TAH)

Market Segmentation by End-user  

  • Hospitals
  • Special Cardiac Centers

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • Turkey
    • Saudi Arabia

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusion

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of The Study

4.4 Market Segmentation

4.4.1 Product

4.4.2 Application

4.4.3 End-users

4.4.4 Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

7.1.1 Background

7.1.2 Cardiac Assist Devices

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Growing Global Prevalence/Incidence of Heart Failure

8.1.2 Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation

8.1.3 Growing Demand for Shared Care Centers & their Importance Post-LVAD

8.2 Market Restraints

8.2.1 High Cost of Cardiac Assist Devices

8.2.2 Stringent & Time-consuming Regulatory Approvals

8.2.3 Complications & Risks Associated with Cardiac Assist Devices

8.3 Market Opportunities and Trends

8.3.1 Technological Advancements

8.3.2 Promising Investigational Cardiac Assist Devices

8.3.3 New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices

9 Market Landscape

9.1 Market Overview

9.2 Market Size and Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Cardiac Assist Devices Market by Product

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

11 Ventricular Assist Devices

11.1 Market Snapshot & Growth Engine

11.2 Market Overview

11.2.1 Market Size & Forecast

11.3 Ventricular Assist Devices Market Segmentation by Product

11.4 Left-Ventricular Assist Devices

11.4.1 Market Overview

11.4.2 Market Size & Forecast

11.5 Other Ventricular Assist Devices

11.5.1 Market Overview

11.5.2 Market Size & Forecast

12 Intra-Aortic Balloon Pump Therapy Devices

12.1 Market Overview

12.2 Market Size & Forecast

13 Total Artificial Heart

13.1 Market Overview

13.2 Market Size & Forecast

14 Cardiac Assist Devices Market by Application

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Bridge to Transplantation (BTT)

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.4 Destination Therapy (DT)

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.5 Other Applications

14.5.1 Market Overview

14.5.2 Market Size & Forecast

15 Cardiac Assist Devices Market by End-Users

15.1 Market Snapshot & Growth Engine

15.2 Market Overview

15.3 Hospitals

15.3.1 Market Overview

15.3.2 Market Size & Forecast

15.4 Specialty Cardiac Centers

15.4.1 Market Overview

15.4.2 Market Size & Forecast

16 Cardiac Assist Devices Market by Geography

16.1 Market Snapshot & Growth Engine

16.2 Overview

17 North America

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 US: Cardiac Assist Devices Market Size & Forecast

17.3.2 Canada: Market Size & Forecast

18 Europe

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 Germany: Cardiac Assist Devices Market Size & Forecast

18.3.2 France: Market Size & Forecast

18.3.3 UK: Market Size & Forecast

18.3.4 Spain: Market Size & Forecast

18.3.5 Italy: Market Size & Forecast

19 APAC

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Key Countries

19.3.1 Japan: Cardiac Assist Devices Market Size & Forecast

19.3.2 China: Market Size & Forecast

19.3.3 Australia: Market Size & Forecast

19.3.4 South Korea: Market Size & Forecast

19.3.5 India: Market Size & Forecast

20 Latin America

20.1 Market Overview

20.2 Market Size & Forecast

20.3 Key Countries

20.3.1 Brazil: Cardiac Assist Devices Market Size & Forecast

20.3.2 Mexico: Market Size & Forecast

20.3.3 Argentina: Market Size & Forecast

21 Middle East and Africa

21.1 Market Overview

21.2 Market Size & Forecast

21.2 Key Countries

21.2.1 Turkey: Cardiac Assist Devices Market Size & Forecast

21.2.2 Saudi Arabia: Market Size & Forecast

22 Competitive Landscape

22.1 Competition Overview

22.2 Market Analysis

22.2.1 Ventricular Assist Devices

22.2.2 IABP

22.2.3 Total Artificial Heart

23 Key Company Profiles

23.1 Abbott

23.1.1 Business Overview

23.1.2 Abbott in Global Cardiac Assist Devices Market

23.1.3 Major Product Offerings

23.1.4 Key Strengths

23.1.5 Key Strategies

23.1.6 Key Opportunities

23.2 Medtronic

23.2.1 Business Overview

23.2.2 Medtronic in Global Cardiac Assist Devices Market

23.2.3 Major Product Offerings

23.2.4 Key Strengths

23.2.5 Key Strategies

23.2.6 Key Opportunities

24 Other Prominent Vendors

24.1 Abiomed

24.1.1 Business Overview

24.1.2 Product Offerings

24.1.3 Key Strengths

24.1.4 Key Strategies

24.1.5 Key Opportunities

24.2 Berlin Heart

24.2.1 Business Overview

24.2.2 Product Offerings

24.2.3 Key Strengths

24.2.4 Key Strategies

24.2.5 Key Opportunities

24.3 Getinge

24.3.1 Business Overview

24.3.2 Product Offerings

24.3.3 Key Strengths

24.3.4 Key Strategies

24.3.5 Key Opportunities

24.4 Syncardia

24.4.1 Business Overview

24.4.2 Product Offerings

24.4.3 Key Strengths

24.4.4 Key Strategies

24.4.5 Key Opportunities

24.5 Teleflex

24.5.1 Business Overview

24.5.2 Product Offerings

24.5.3 Key Strengths

24.5.4 Key Strategies

24.5.5 Key Opportunities

24.6 Zeon Medical

24.6.1 Business Overview

24.6.2 Product Offerings

24.6.3 Key Strengths

24.6.4 Key Strategies

24.6.5 Key Opportunities

24.7 Tokai Medical Products

24.7.1 Business Overview

24.7.2 Product Offerings

24.7.3 Key Strengths

24.7.4 Key Strategies

24.7.5 Key Opportunities

24.8 SENKO Medical Instrument

24.8.1 Business Overview

24.8.2 Product Offerings

24.8.3 Key Strengths

24.8.4 Key Strategies

24.8.5 Key Opportunities

24.9 Insightra Medical

24.9.1 Business Overview

24.9.2 Product Offerings

24.9.3 Key Strengths

24.9.4 Key Strategies

24.9.5 Key Opportunities

24.10 Reliantheart

24.10.1 Business Overview

24.10.2 Product Offerings

24.10.3 Key Strengths

24.10.4 Key Strategies

24.10.5 Key Opportunities

24.11 Pulsecath

24.11.1 Business Overview

24.11.2 Product Offerings

24.11.3 Key Strengths

24.11.4 Key Strategies

24.11.5 Key Opportunities

24.12 Jarvik Heart

24.12.1 Business Overview

24.12.2 Product Offerings

24.12.3 Key Strengths

24.12.4 Key Strategies

24.12.5 Key Opportunities

25 Report Summary

25.1 Key Takeaways

25.2 Strategic Recommendations

25.3 Quantitative Summary

25.3.1 Product

25.3.2 Application

25.3.3 End-users

25.3.4 Geography

26 Appendix

26.1 Abbreviations

List of Exhibits 

Exhibit 1               Segmentation of Global Cardiac Assist Devices Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Various Treatment Options for Heart Failure

Exhibit 4               Impact of Growing Global Prevalence/Incidence of Heart Failure

Exhibit 5               Global Prevalence of Heart Failure in Adults

Exhibit 6               Prevalence of Heart Failure in Selected Countries 2017

Exhibit 7               Impact of Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation

Exhibit 8               Heart Transplantation Waiting List in Key Countries/Regions 2017

Exhibit 9               Number of Heart Transplantations Performed in 2017

Exhibit 10             Comparison of Number of Heart Transplantations Performed in India 1994-2014 Versus 2016-2017

Exhibit 11             Impact of Growing Demand for Shared Care Centers & their Importance Post-LVAD Implantation

Exhibit 12             Shared Care Model Framework

Exhibit 13             Impact of High Cost of Cardiac Assist Devices

Exhibit 14             Impact of Stringent & Time-consuming Regulatory Approvals

Exhibit 15             Impact of Complications & Risks Associated with Cardiac Assist Devices

Exhibit 16             Impact of Technological Advancements

Exhibit 17             First-generation Cardiac Assist Devices

Exhibit 18             Impact of Promising Investigational Cardiac Assist Devices

Exhibit 19             Impact of New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices

Exhibit 20             Global Cardiac Assist Devices Market 2019−2025 ($ million)

Exhibit 21             Five Force Analysis 2019

Exhibit 22             Incremental Growth by Product 2019 & 2025

Exhibit 23             Global Cardiac Assist Devices Market by Product

Exhibit 24             Global Market by Product 2019 & 2025 (%)

Exhibit 25             Global Market by Product: Incremental Growth

Exhibit 26             Global Market by Product: Absolute Growth

Exhibit 27             Incremental Growth by Product 2019 & 2025

Exhibit 28             Global Ventricular Assist Devices Market: Incremental Growth Versus Absolute Growth Comparison

Exhibit 29             Global Ventricular Market 2019−2025 ($ million)

Exhibit 30             Global Ventricular Market by Product

Exhibit 31             Global Ventricular Market by Product 2019 & 2025 (%)

Exhibit 32             Global Ventricular Market by Product 2019-2025 ($ million)

Exhibit 33             Global Ventricular Market by Product 2019-2025 (%)

Exhibit 34             Global LVADs Market 2019−2025 ($ million)

Exhibit 35             Global Other Ventricular Assist Devices Market 2019−2025 ($ million)

Exhibit 36             Global Intra-aortic Balloon Pump Therapy Devices Market: Incremental Growth Versus Absolute Growth Comparison

Exhibit 37             Global Intra-aortic Balloon Pump Therapy Devices Market 2019−2025 ($ million)

Exhibit 38             Global Total Artificial Heart Market: Incremental Growth Versus Absolute Growth Comparison

Exhibit 39             Global Total Artificial Heart Market 2019−2025 ($ million)

Exhibit 40             Incremental Growth by Application 2019 & 2025

Exhibit 41             Global Cardiac Assist Devices Market by Application

Exhibit 42             Global Market by Application 2019 & 2025 (%)

Exhibit 43             Global Market by Application: Incremental Growth

Exhibit 44             Global Market by Application: Absolute Growth

Exhibit 45             Global Market by Bridge to Transplant: Incremental Growth Versus Absolute Growth

Exhibit 46             Global Market by Bridge to Transplantation 2019−2025 ($ million)

Exhibit 47             Global Market by Destination Therapy: Incremental Growth Versus Absolute Growth

Exhibit 48             Global Market by Destination Therapy 2019−2025 ($ million)

Exhibit 49             Global Market by Other Applications: Incremental Growth Versus Absolute Growth Comparison

Exhibit 50             Global Market by Other Applications 2019−2025 ($ million)

Exhibit 51             Incremental Growth by End-users 2019 & 2025

Exhibit 52             Global Market by End-users

Exhibit 53             Global Market by End-users 2019 & 2025 (%)

Exhibit 54             Global Market by End-users: Incremental Growth

Exhibit 55             Global Market by End-users: Absolute Growth

Exhibit 56             Global Market by Hospitals: Incremental Growth Versus Absolute Growth Comparison

Exhibit 57             Global Market by Hospitals 2019−2025 ($ million)

Exhibit 58             Global Market by Specialty Cardiac Centers: Incremental Growth Versus Absolute Growth Comparison

Exhibit 59             Global Market by Specialty Cardiac Centers 2019−2025 ($ million)

Exhibit 60             Incremental Growth by Geography 2019 & 2025

Exhibit 61             Global Cardiac Assist Devices Market by Geography

Exhibit 62             Global Market by Geography 2019 & 2025 (%)

Exhibit 63             Global Market by Geography: Incremental Growth

Exhibit 64             Global Market by Geography: Incremental Growth

Exhibit 65             Cardiac Assist Devices Market in North America: Incremental Growth Versus Absolute Growth Comparison

Exhibit 66             Market in North America 2019–2025 ($ million)

Exhibit 67             Incremental Growth in North America 2019 & 2025

Exhibit 68             Market in US 2019–2025 ($ million)

Exhibit 69             Market in Canada 2019–2025 ($ million)

Exhibit 70             Cardiac Assist Devices Market in Europe: Incremental Growth Versus Absolute Growth Comparison

Exhibit 71             Market in Europe 2019–2025 ($ million)

Exhibit 72             Incremental Growth in Europe 2019 & 2025

Exhibit 73             Market in Germany 2019–2025 ($ million)

Exhibit 74             Market in France 2019–2025 ($ million)

Exhibit 75             Market in UK 2019–2025 ($ million)

Exhibit 76             Market in Spain 2019–2025 ($ million)

Exhibit 77             Market in Italy 2019–2025 ($ million)

Exhibit 78             Cardiac Assist Devices Market in APAC: Incremental Growth Versus Absolute Growth Comparison

Exhibit 79             Market in APAC 2019–2025 ($ million)

Exhibit 80             Incremental Growth in APAC 2019 & 2025

Exhibit 81             Market in Japan 2019–2025 ($ million)

Exhibit 82             Market in China 2019–2025 ($ million)

Exhibit 83             Market in Australia 2019–2025 ($ million)

Exhibit 84             Market in South Korea 2019–2025 ($ million)

Exhibit 85             Market in India 2019–2025 ($ million)

Exhibit 86             Cardiac Assist Devices Market in Latin America: Incremental Versus Absolute Growth Comparison

Exhibit 87             Market in Latin America 2019–2025 ($ million)

Exhibit 88             Incremental Growth in Latin America 2019 & 2025

Exhibit 89             Market in Brazil 2019–2025 ($ million)

Exhibit 90             Market in Mexico 2019–2025 ($ million)

Exhibit 91             Market in Argentina 2019–2025 ($ million)

Exhibit 92             Cardiac Assist Devices Market in Middle East & Africa: Incremental Growth Versus Absolute Growth Comparison

Exhibit 93             Market in Middle East and Africa 2019–2025 ($ million)

Exhibit 94             Incremental Growth in Middle East and Africa 2019 & 2025

Exhibit 95             Market in Turkey 2019–2025 ($ million)

Exhibit 96             Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 97             Abbott: R&D Expenditure in FY2016, FY2017 and FY2018 ($ million)

Exhibit 98             Abbott: Sales Breakdown by Segments in FY2017 and FY2018 ($ million)

Exhibit 99             Abbott Sales Breakdown by Geography 2018 (%)

Exhibit 100          Medtronic Sales Breakdown by Segments FY2018 (%)

Exhibit 101          Medtronic R&D Expenditure FY2016-FY2018 ($ million)

Exhibit 102          Medtronic Revenue Breakdown by Geography FY2018 (%)

Exhibit 103          Medtronic Revenue by Business Segments in FY2017 and FY2018 ($ million)

               

List of Tables

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  New York Heart Association Classification of Heart Failure

Table 4                  Potential Benefits of Shared Care Model for Various Stakeholders

Table 5                  Cost of Various Cardiac Assist Devices

Table 6                  Complications Related to Cardiac Assist Devices & Their Prevalence

Table 7                  Popular First, Second, and Third-generation Cardiac Assist Devices

Table 8                  List of Promising Investigational Cardiac Assist Devices

Table 9                  List of Cardiac Assist Devices Approved/Launched in Various Countries

Table 10               List of Cardiac Assist Devices Approved for New Indications

Table 11               Global Ventricular Assist Market: Vendors Ranking

Table 12               Global Ventricular Assist Market: Vendors Ranking

Table 13               Abbott Group: Product Offerings

Table 14               Medtronic: Major Clinical Trials for Heart Failure Treatment

Table 15               Medtronic: Product Offerings

Table 16               Abiomed: Key Product Offerings

Table 17               Berlin Heart: Key Product Offerings

Table 18               Getinge: Key Product Offerings

Table 19               SynCardia: Key Product Offerings

Table 20               Teleflex: Key Product Offerings

Table 21               ZEON MEDICAL: Key Product Offerings

Table 22               Tokai Medical Products: Key Product Offerings

Table 23               SENKO MEDICAL INSTRUMENT: Key Product Offerings

Table 24               Insightra Medical: Key Product Offerings

Table 25               ReliantHeart: Key Product Offerings

Table 26               PulseCath: Key Product Offerings

Table 27               Jarvik Heart: Key Product Offerings

Table 28               Global Cardiac Assist Devices Market by Product ($ million)

Table 29               Global Market by Product (%)

Table 30               Global Market by Application ($ million)

Table 31               Global Market by Application (%)

Table 32               Global Market by End-users ($ million)

Table 33               Global Market by End-users (%)

Table 34               Global Market by Geography ($ million)

Table 35               Global Market by Geography (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date